Graftys develops, manufactures and markets patented synthetic orthopedic biomaterials, in particular a new generation of resorbable calcium-phosphate cements for reconstructive surgery. The bone cement market is one of the fastest growing sgements of the orthopedic market. The company’s key products are commercialised in more than 25 countries, including Europe and the United States of America.

For more information: